BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 26023082)

  • 1. β-Cryptoxanthin Synergistically Enhances the Antitumoral Activity of Oxaliplatin through ΔNP73 Negative Regulation in Colon Cancer.
    San Millán C; Soldevilla B; Martín P; Gil-Calderón B; Compte M; Pérez-Sacristán B; Donoso E; Peña C; Romero J; Granado-Lorencio F; Bonilla F; Domínguez G
    Clin Cancer Res; 2015 Oct; 21(19):4398-409. PubMed ID: 26023082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells.
    Slaninová V; Heron-Milhavet L; Robin M; Jeanson L; Aissanou A; Kantar D; Tosi D; Bréhélin L; Gongora C; Djiane A
    BMC Cancer; 2024 May; 24(1):587. PubMed ID: 38741073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mahanine synergistically enhances cytotoxicity of 5-fluorouracil through ROS-mediated activation of PTEN and p53/p73 in colon carcinoma.
    Das R; Bhattacharya K; Sarkar S; Samanta SK; Pal BC; Mandal C
    Apoptosis; 2014 Jan; 19(1):149-64. PubMed ID: 24052409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin Enhances the Effects of 5-Fluorouracil and Oxaliplatin in Inducing Gastric Cancer Cell Apoptosis Both In Vitro and In Vivo.
    Zhou X; Wang W; Li P; Zheng Z; Tu Y; Zhang Y; You T
    Oncol Res; 2016 Jan; 23(1-2):29-34. PubMed ID: 26802648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TAp73 is one of the genes responsible for the lack of response to chemotherapy depending on B-Raf mutational status.
    Herreros-Villanueva M; Muñiz P; García-Girón C; Cavia-Saiz M; del Corral MJ
    J Transl Med; 2010 Feb; 8():15. PubMed ID: 20146801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxaliplatin and Infliximab Combination Synergizes in Inducing Colon Cancer Regression.
    Li W; Xu J; Zhao J; Zhang R
    Med Sci Monit; 2017 Feb; 23():780-789. PubMed ID: 28190020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxaliplatin promotes siMAD2L2‑induced apoptosis in colon cancer cells.
    Ma L; Li X; Zhao X; Sun H; Kong F; Li Y; Sui Y; Xu F
    Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baicalin enhances the chemotherapy sensitivity of oxaliplatin-resistant gastric cancer cells by activating p53-mediated ferroptosis.
    Shao L; Zhu L; Su R; Yang C; Gao X; Xu Y; Wang H; Guo C; Li H
    Sci Rep; 2024 May; 14(1):10745. PubMed ID: 38730240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRMT1 inhibition induces differentiation of colon cancer cells.
    Plotnikov A; Kozer N; Cohen G; Carvalho S; Duberstein S; Almog O; Solmesky LJ; Shurrush KA; Babaev I; Benjamin S; Gilad S; Kupervaser M; Levin Y; Gershovits M; Ben-Avraham D; Barr HM
    Sci Rep; 2020 Nov; 10(1):20030. PubMed ID: 33208761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor regression following intravenous administration of a tumor-targeted p73 gene delivery system.
    Lemarié F; Croft DR; Tate RJ; Ryan KM; Dufès C
    Biomaterials; 2012 Mar; 33(9):2701-9. PubMed ID: 22200536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-Bromopyruvate as inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs.
    Ihrlund LS; Hernlund E; Khan O; Shoshan MC
    Mol Oncol; 2008 Jun; 2(1):94-101. PubMed ID: 19383331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of rCCK96-104PE38 Targeted Drug in the General Surgical Treatment of Colon Cancer.
    Cao W; Zhang B; Liu Y
    Biomed Res Int; 2022; 2022():7145606. PubMed ID: 35722465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-Molecule Prodigiosin Restores p53 Tumor Suppressor Activity in Chemoresistant Colorectal Cancer Stem Cells via c-Jun-Mediated ΔNp73 Inhibition and p73 Activation.
    Prabhu VV; Hong B; Allen JE; Zhang S; Lulla AR; Dicker DT; El-Deiry WS
    Cancer Res; 2016 Apr; 76(7):1989-99. PubMed ID: 26759239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Cancer via p73 Activation and Degradation of Mutant p53.
    Zhang S; Zhou L; Hong B; van den Heuvel AP; Prabhu VV; Warfel NA; Kline CL; Dicker DT; Kopelovich L; El-Deiry WS
    Cancer Res; 2015 Sep; 75(18):3842-52. PubMed ID: 26294215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p73 - NAV3 axis plays a critical role in suppression of colon cancer metastasis.
    Uboveja A; Satija YK; Siraj F; Sharma I; Saluja D
    Oncogenesis; 2020 Feb; 9(2):12. PubMed ID: 32029709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of the deregulated TP73 isoforms expression in cancer.
    Rodríguez N; Peláez A; Barderas R; Domínguez G
    Clin Transl Oncol; 2018 Jul; 20(7):827-836. PubMed ID: 29230693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic Intra-p53 Family Member Interactions in Human Cancers.
    Ferraiuolo M; Di Agostino S; Blandino G; Strano S
    Front Oncol; 2016; 6():77. PubMed ID: 27066457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p73 promotes glioblastoma cell invasion by directly activating POSTN (periostin) expression.
    Landré V; Antonov A; Knight R; Melino G
    Oncotarget; 2016 Mar; 7(11):11785-802. PubMed ID: 26930720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-induced DNp73 stabilization regulates Vegf-A expression and tumor angiogenesis similar to TAp73.
    Dulloo I; Hooi PB; Sabapathy K
    Cell Cycle; 2015; 14(22):3533-9. PubMed ID: 26267146
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Wang J; Rani N; Jakhar S; Redhu R; Kumar S; Kumar S; Kumar S; Devi B; Simal-Gandara J; Shen B; Singla RK
    Front Plant Sci; 2023; 14():1236123. PubMed ID: 37860248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.